跳至主要内容
临床试验/JPRN-UMIN000024536
JPRN-UMIN000024536已完成未知

Intervention Study for the effect of Istradefylline on onset of Dyskinesia in Patients with Parkinson's Disease. - ODYSSEI Study(Onset of Dyskinesia and Safety/Efficacy of Istradefylline)

Fukuoka University0 个研究点目标入组 214 人开始时间: 2016年10月25日最近更新:
适应症

试验速览

阶段
未知
状态
已完成
入组人数
214

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
30years-old 至 80years-old(—)
性别
All

入选标准

  • 未提供

排除标准

  • (1)Current use of istradefylline (within 1 year prior to study entry) (2)Current use of amantadine (within 3 months prior to study entry) (3)Current use of an investigational drug (within 4 months prior to study entry.) (4)Patients with dementia or a score of 23 or less on the Mini-Mental State Examination (MMSE) (5)Patients with a previous history of brain surgery for the treatment of parkinson's disease. (6)Current use or plan to administer levodopa/carbidopa intestinal gel (7)Patients with moderate to severe hepatic disorder (8)Current use of a strong inhibitor of CYP3A4 (within 14days prior to study entry) (9)Current use of typical and atypical antipsychotics (within 3 months prior to study entry) (10)Female patients who are pregnant, trying to become pregnant or nursing (lactating) an infant. (11)Patients who are in the Investigator's judgment unlikely to comply with medical regimens or study requirements.

研究者

相似试验